Treatment of peri‐menopausal women: potential long‐term therapy with a depot GnRH agonist combined with hormonal replacement therapy
- 1 February 1992
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (s7) , 13-17
- https://doi.org/10.1111/j.1471-0528.1992.tb13533.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterolPublished by Elsevier ,2021
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomataFertility and Sterility, 1989
- Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist BuserelinFertility and Sterility, 1988
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depotFertility and Sterility, 1987
- Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomasFertility and Sterility, 1987
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985